Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more
Advertisement

Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more

By Sreeja Biswas

  • 27 Dec 2024
Premium
Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more
Dr Saloni Wagh, MD, Supriya Lifescience

Bulk-drugs maker Supriya Lifescience Ltd, which was founded in 1987 and operates in therapeutic segments such as antihistamines, anti-allergics, vitamins, and anti-asthmatics, expects a shift in its revenue mix in coming years with a larger contribution from contract manufacturing and finished formulations, a top executive told VCCircle.  The Mumbai-listed company aims ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News